AT

Alasdair Thong

Bioeconomy Development

London, England

Invests in

Locations:

  • Min Investment:

    $250,000.00
  • Max Investment:

    $1,000,000.00
  • Target Investment:

    $500,000.00

Work Experience

  • Head of Sovereign Innovation

    2025

    Leading strategic partnerships at the national level, enabling developing bioeconomies to rapidly build sustainable, end-to-end biotechnology ecosystems. Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of partners across academia, biotech, and the largest biopharma, Alloy democratizes access to pre-competitive tools, technologies, services, and company creation capabilities that are foundational for discovering and developing therapeutic biologics across six modalities: antibodies, TCRs, genetic medicines, peptides, cell therapies, and drug delivery. https://alloytx.com

  • Board Observer

    2025

    representing Mubadala Capital

  • Co-Founder and Non-Executive Director

    2021

    Multiomic Health is a next-generation precision medicine venture, integrating computational systems biology with laboratory science to develop and commercialize new therapeutics for metabolic syndrome — the world’s largest healthcare burden. https://multiomic.health

  • BD, Licensing, Acquisitions and Investments

    2024

    The Ellison Institute of Technology’s mission is to develop and deploy technology in pursuit of solving some of humanity’s most challenging and enduring problems. Guided by world leaders, scientists and entrepreneurs, EIT seeks to accelerate innovation in health and medical science, food security and sustainable agriculture, climate change and clean energy, and government innovation and era of artificial intelligence. https://eit.org

  • Venture Partner

    2020

    Mubadala Capital is the wholly owned asset management arm of Mubadala Investment Company with over USD$16 billion AUM. Mubadala is an Abu Dhabi sovereign wealth investor with USD$250bn+ AUM. https://www.mubadala.com/en/what-we-do/capital/ventures

  • Venture Partner: Healthcare

    2020

    Ada Ventures is the inclusive venture firm. Ada Ventures finds and funds extraordinary talent building breakthrough ideas for the hardest problems we face. We are investing out of our second fund and we invest £250,000 - £1m in UK technology companies across climate, economic empowerment and healthcare & ageing. If you are raising seed capital for your start-up you can apply directly below: Fundraising: https://adaventures.typeform.com/AdaSubmissions https://www.adaventures.com/

  • Founding Partner

    2019

    Selvedge Venture is a Venture Capital management and advisory firm with a focus on deep tech in life sciences and healthcare. https://selvedgeventure.com

2023

  • Investor

    2023

    via Mubadala Capital

2021

  • Board Observer

    2021

  • Investor/Advisor

    2021

2021

  • Investor

    2021